Evidence map›Paper›PMID 38368463›Full record

ArticleScientific reports2024

Bone marrow stromal cell-derived hepcidin has antimicrobial and immunomodulatory activities.

Miklós Krepuska, Balázs Mayer, Lynn Vitale-Cross, Vamsee D Myneni, Michael K Boyajian, Krisztián Németh, Ildikó Szalayova, Ted Cho, Ian McClain-Caldwell, Aaron D Gingerich and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Miklós Krepuska *National Institutes of Health, NIDCR, ASCS, Bethesda, MD, USA.
Balázs Mayer *National Institutes of Health, NIDCR, ASCS, Bethesda, MD, USA.
Lynn Vitale-Cross *National Institutes of Health, NIDCR, ASCS, Bethesda, MD, USA.
Vamsee D MyneniNational Institutes of Health, NIDCR, ASCS, Bethesda, MD, USA.
Michael K BoyajianNational Institutes of Health, NIDCR, ASCS, Bethesda, MD, USA.
Krisztián NémethNational Institutes of Health, NIDCR, ASCS, Bethesda, MD, USA.
Ildikó SzalayovaNational Institutes of Health, NIDCR, ASCS, Bethesda, MD, USA.
Ted ChoNational Institutes of Health, NIDCR, ASCS, Bethesda, MD, USA.
Ian McClain-CaldwellNational Institutes of Health, NIDCR, ASCS, Bethesda, MD, USA.
Aaron D GingerichDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.
Huiling HanIntrinsic Life Sciences, La Jolla, CA, USA.
Mark WestermanIntrinsic Life Sciences, La Jolla, CA, USA.
Balázs RadaDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, USA. radab@uga.edu.
Éva MezeyNational Institutes of Health, NIDCR, ASCS, Bethesda, MD, USA.
National Institutes of Health · USIntrinsic LifeSciences (United States) · USSemmelweis University · HUUniversity of Georgia · US

Funding

Contribution of bone marrow cells to tissue regeneration, immune function and hematopoiesisZIADE000714 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI MEZEY, EVA M. · 2009 to 2025
$25.3M
NIDCR DIR Production FacilitiesZIBDE000730 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI ROBEY, PAMELA G · 2009 to 2014
$1.2M
Development of novel cell and gene therapiesZIACL002120 · CLC · CLINICAL CENTER · PI STRONCEK, DAVID · 2009 to 2025
$0k
Intramural NIH HHS ZIA CL002120Intramural NIH HHS ZIA DE000714Intramural NIH HHS ZIB DE000730
6 · The paper itself

Abstract

Bone marrow stromal cells (BMSCs) have immunomodulatory activities in numerous species and have been used in clinical trials. BMSCs also make antibacterial agents. Since hepcidin is known to have antimicrobial effects in fish, we wondered if it might also be used as an antimicrobial agent by mammalian BMSCs. In the present study, we show hepcidin expression in both mouse (mBMSC) and human BMSCs (hBMSC). We observed a hBMSC hepcidin-dependent degradation of ferroportin in HEK-293 reporter cells in vitro. In human and mouse bone marrows (BM) we detected hepcidin-positive BMSCs in close proximity to hematopoietic progenitors. The conditioned culture medium of hBMSCs significantly reduced bacterial proliferation that was partially blocked by a hepcidin-neutralizing antibody. Similarly, medium in which hepcidin-deficient (Hamp

Indexed as

Anti-Infective AgentsMesenchymal Stem CellsAnimalsBone Marrow CellsHEK293 CellsHepcidinsHumansInflammationMammalsMiceAnti-Infective AgentsHepcidins

Identifiers

PMID38368463
PMCPMC10874407
OpenAlexW4391914355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.